Relationship between mammographic breast density and tamoxifen in women with breast cancer

Breast Journal

Volumn 10, Issue 4, 2004, Pages 313-317

  Tiersten, Amy ^a   Ng, Yin Y ^b   Pile Spellman, Eliza ^c   Nelsen, Caron ^d   Noguera Irizarry, Wanda ^c   Brafman, Rebecca ^d   Russo, Donna ^c   Troxel, Andrea ^c   Johnson, Alan ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d NONE

Author keywords

Breast cancer detection; Breast density; Mammography; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DIAGNOSTIC ACCURACY; DRUG EFFECT; EARLY DIAGNOSIS; FEMALE; HUMAN; IMAGE ANALYSIS; MAMMOGRAPHY; MENOPAUSE; ORGAN SIZE; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; OBSERVER VARIATION; POSTMENOPAUSE; RETROSPECTIVE STUDIES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SENSITIVITY AND SPECIFICITY; TAMOXIFEN;

EID: 3142724820     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2004.21332.x     Document Type: Article

References (23)

1. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin N Am 1992;30:187-210.
2. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-87.
3. Freedman M, San Martin J, O'Gorman J, et al. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst 2001;93:51-56.
4. Margolin FR, Denny SR, Gelfand CA, Jacobs RP. Mammographic changes after hormone replacement therapy in patients who have undergone breast irradiation. AJR Am J Roentgenol 1999;172:147-50.
5. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001;285:171-76.
6. Litherland JC, Evans AJ, Wilson ARM. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radiol 1997;52:276-79.
7. Vachon CM, Sellers TA, Vierkant RA, Wu FF, Brandt KR. Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev 2002;11:1382-88.
8. Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2001;9:911-15.
9. Tamoxifen for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;351:1451-67.
10. Powles TJ. The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 1992;340:1145-47.
11. Fleiss JL. Statistical Metbods for Rates and Proportions, 2nd ed. New York: John Wiley & Sons, 1981.
12. White J. Breast density and cancer risk: what is the relationship? J Natl Cancer Inst 2000;6:443.
13. Cole MP, Jones CTA, Todd IDH. A new antiestrogenic agent in late breast cancer: an early clinical appraisal of ICI 46,474. Br J Cancer 1971;25:270-75.
14. Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN. Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 1995;13:513-29.
15. Furr BJ, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 1984;25:127-205.
16. Heel RC, Brogden RN, Speight TM, Avery GS. Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs 1978;16:1-24.
17. Son HJ, Oh KK. Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery. AJR Am Roentgenol 1999;173:905-9.
18. Atkinson C, Warren R, Bingham SA, Day NE. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999;10:863-66.
19. Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J. Effect of tamoxifen on mammographic breast density. Cancer Epidemiol Biomarkers Prev 2000;9:917-21.
20. Boyd NF, Jensen HM, Cooke G, Han HL. Relationship between mammographic and histologic risk factors for breast cancer. J Natl Cancer Inst 1992;84:1170-79.
21. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 1996;167:1261-65.
22. Grove JS, Goodman MJ, Gilbert FI Jr, Mi MP. Factors associated with mammographic pattern. Br J Radiol 1985;58:21-25.
23. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 2003;7:556-58.